ROFACT
ROFACT
Approved
DIN Number
00343617
Drug Class
Human
Market Date
Dec 31, 1977
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00343617
AIG Number0105824001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04AB02 RIFAMPICIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:16.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIFAMPINActive
Strength: 300 MG
Monograph: RIFAMPIN